Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial.

Hovens, M M C

Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial. [electronic resource] - Diabetes, obesity & metabolism Aug 2008 - 668-74 p. digital

Publication Type: Journal Article; Randomized Controlled Trial

1463-1326

10.1111/j.1463-1326.2007.00794.x doi


Aspirin--administration & dosage
Atherosclerosis--drug therapy
C-Reactive Protein--drug effects
Cross-Over Studies
Diabetes Mellitus, Type 2--drug therapy
Diabetic Angiopathies--prevention & control
Female
Humans
Interleukin-6--metabolism
Male
Middle Aged
Platelet Aggregation Inhibitors--administration & dosage
Prospective Studies
Treatment Outcome